Physician

Vikram Reddy Vadyala, MD

According to 2025 Medicare claims, Vikram Vadyala, MD (NPI: 1497985188) practices internal medicine in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is VIKRAM VADYALA PLLC (NPI: 1336530427; TIN: 471394805) and primary practice location at 79707-9750. Vadyala is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Vadyala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 530 traditional Medicare patients, billed 7,335 HCPCS/CPT codes, and received $379,554 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 5,345 prescription claims across 285 beneficiaries totaling $899,647 in drug costs, led by Ozempic (Semaglutide). DME data shows 18 claims. Open Payments data shows 4 records totaling $73. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $125,233 to $379,554. Similarly, Part D prescription costs have moved sharply higher in recent years, from $16,584 to $899,647. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,050 and ending at $5,160.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	315	1,322	$125,233
2016	284	1,363	$117,236
2017	344	1,561	$114,825
2018	472	4,751	$328,222
2019	533	5,152	$342,618
2020	603	4,474	$288,340
2021	565	5,895	$364,344
2022	593	6,061	$365,069
2023	576	5,781	$366,851
2024	530	7,335	$379,554

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	163	507	$16,584
2016	201	524	$13,812
2017	225	641	$23,414
2018	230	1,278	$96,411
2019	305	2,128	$181,811
2020	406	2,652	$304,274
2021	299	4,214	$608,478
2022	286	5,244	$811,049
2023	267	5,348	$840,033
2024	285	5,345	$899,647

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	111	$4,604
2017	N/R	92	$3,335
2018	N/R	43	$1,014
2019	N/R	N/R	N/R
2020	N/R	22	$2,553
2021	N/R	41	$2,749
2022	N/R	56	$4,836
2023	N/R	20	$3,280
2024	N/R	18	$4,716

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	281	345	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	175	385	$73
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	336	3,853	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	155	332	$11
36415	Insertion of needle into vein for collection of blood sample	166	370	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	176	6,450	$208,670
Eliquis	Apixaban	115	5,783	$107,968
Jardiance	Empagliflozin	74	4,500	$86,590
Mounjaro	Tirzepatide	51	1,512	$54,628
Trulicity	Dulaglutide	47	1,438	$48,095

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	18	$4,716

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$73	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vikram Reddy Vadyala, MD?

Tedicare shows public-source Medicare data for Vikram Reddy Vadyala, MD (NPI 1497985188), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vikram Reddy Vadyala, MD have ACO affiliation data?

Vikram Reddy Vadyala, MD is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Vikram Reddy Vadyala, MD?

Vikram Reddy Vadyala, MD is linked to VIKRAM VADYALA PLLC (billing NPI 1336530427) in the available physician profile data.

Does Vikram Reddy Vadyala, MD have Open Payments data?

Vikram Reddy Vadyala, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.